Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Omega Therapeutics Inc (NQ: OMGA )

6.150 -0.160 (-2.54%)
Streaming Delayed Price Updated: 11:10 AM EDT, Mar 30, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 23,576
Open 6.400
Bid (Size) 6.130 (1)
Ask (Size) 6.260 (1)
Prev. Close 6.310
Today's Range 6.100 - 6.659
52wk Range 1.975 - 11.98
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Omega Therapeutics Announces Clinical Supply Agreement to Evaluate the Combination of OTX-2002 and Atezolizumab in Hepatocellular Carcinoma
From Omega Therapeutics
Via Globe NewsWire
Why Bed Bath & Beyond Shares Are Trading Lower By Around 24%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers 
Via Benzinga

Performance

YTD
+6.77%
+6.77%
1 Month
+5.49%
+5.49%
3 Month
+16.04%
+16.04%
6 Month
+10.41%
+10.41%
1 Year
-5.53%
-5.53%

More News

Read More
Omega Therapeutics Could Offer 'Intriguing' Liver Cancer Drug, Analyst Says
Via Benzinga
Omega Therapeutics Touts Encouraging Preclinical Data In Liver Cancer Animal Models
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 10, 2023
Via Benzinga
Omega Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
From Omega Therapeutics
Via Globe NewsWire
Over $19M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying
Via Benzinga
Omega Therapeutics Announces $40 Million Registered Direct Offering of Common Stock
From Omega Therapeutics
Via Globe NewsWire
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Omega Therapeutics to Present Trial-in-Progress Poster for Phase 1/2 MYCHELANGELO™ I Study at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium
From Omega Therapeutics
Via Globe NewsWire
Why Tivic Health Systems Are Trading Lower By 55%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Nasdaq Up 50 Points; Gold Rises Over 1%
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
TSMC, CommScope Holding And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Omega Therapeutics Earnings Perspective: Return On Capital Employed
Via Benzinga
The Daily Biotech Pulse: FDA Signs Off Cancer Therapy Trials For NexImmune, Omega Therapeutics, Endo To Develop Rare Hereditary Skin Disease Candidate
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 23, 2022
Via Benzinga
Omega Therapeutics Gets FDA Nod For Initial-Stage Liver Cancer Study
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Why SciSparc Is Trading Higher By 68%, Here Are 48 Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Why Revlon Shares Jumped 90%; Here Are 83 Biggest Movers From Yesterday
Via Benzinga
Coinbase, Moderna And 56 Biggest Movers From Yesterday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.